Final Overall Survival and Molecular Data Associated with Clinical Outcomes in Patients Receiving Ipatasertib and Abiraterone in the Phase 3 IPATential150 Trial.
de Bono JS, He M, Shi Z, Nowicka M, Bracarda S, Sternberg CN, Chi KN, Olmos D, Sandhu S, Massard C, Matsubara N, Chen G, Bienz NS, Canter D, Wongchenko M, Sweeney C.
de Bono JS, et al. Among authors: he m.
Eur Urol. 2025 Jan 29:S0302-2838(24)02771-4. doi: 10.1016/j.eururo.2024.12.015. Online ahead of print.
Eur Urol. 2025.
PMID: 39884884